LATEST
Silgan / Trivium: minority stakeBF International Best Fields Best Food / DiagramOpenWorld agreed to acquire Blocksight HoldingsMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
ClosedPublished 14 Mar 2024

First Wave BioPharma, Inc. /
ImmunogenX

First Wave BioPharma, Inc. Completes Business Combination With ImmunogenX

Buy side: First Wave BioPharma, Inc.
Buy sideFirst Wave BioPharma, Inc.
Target: ImmunogenX
TargetImmunogenX
Source · 14 Mar 2024Source-verified
See the source
Buy side: First Wave BioPharma, Inc.
Buy sideFirst Wave BioPharma, Inc.
Target: ImmunogenX
TargetImmunogenX
01 / BuyerFirst Wave BioPharma, Inc.
02 / TargetImmunogenX
Source-verified
01

What happened

On March 13, 2024, First Wave BioPharma, Inc. completed its business combination with ImmunogenX. ImmunogenX is developing Latiglutenase.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

First Wave BioPharma, Inc. Completes Business Combination With ImmunogenX

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Also stated

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.